Global Companion Diagnostic
Market Report
2024
Companion Diagnostic Market Report 2024 (Global Edition)
Global Companion Diagnostic market size was USD 5.71 Billion in 2022 and it is forecasted to reach USD 14.31 Billion by 2030. Companion Diagnostic Industry's Compound Annual Growth Rate will be 13.6% from 2023 to 2030.
The base year for the calculation is 2023 and 2019 to 2023 will be historical period. The year 2024 will be estimated one while the forecasted data will be from year 2025 to 2031. When we deliver the report that time we updated report data till the purchase date.
PDF Access: Password protected PDF file, Excel File Access: Quantitative data, PPT Report Access: For the presentation purpose, Cloud Access: Secure Company Account Access.
| Share your contact details to receive free updated sample copy/pages of the recently published edition of Companion Diagnostic Market Report 2024.
Global Companion Diagnostic Market Report 2024 Market Size Split by Indication (Cancer, Infectious Diseases, Neurological Diseases, Others), by End User (Pharmaceutical & Biopharmaceutical Companies, ...
Global Companion Diagnostic market size was USD 5.71 Billion in 2022 and it is forecasted to reach USD 14.31 Billion by 2030. Companion Diagnostic Industry's Compound Annual Growth Rate will be 13.6% from 2023 to 2030.
| Base Year | 2023 |
| Historical Data Time Period | 2019-2023 |
| Forecast Period | 2024-2031 |
| Global Companion Diagnostic Market Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 13.6% |
| Market Split by Indication |
|
| Market Split by End User |
|
| Market Split by Technology |
|
| List of Competitors |
|
| Regional Analysis |
|
Country Analysis |
|
Key Qualitative Information Covered |
|
Report scope is customizable as we have a huge database of Companion Diagnostic industry. We can deliver an exclusive report Edition/Consultation as per your data requirements. Request for your Free Sample Pages.
Companion Diagnostic Market is Segmented as below. Particular segment of your interest can be provided without any additional cost. Download the Sample Pages!
Companion Diagnostic Market Report Description
Introduction of Companion Diagnostic
The companion diagnostic is a medical device, which provides information that is essential for the safe and effective use of a corresponding drug or biological product. Companion diagnostics are typically highly tailored or targeted drug treatment. It helps a healthcare professional to know whether the benefits of a drug or treatment for a patient will balance any serious side effects or risks. Furthermore, companion diagnostics are used for oncology treatment and other types of companion diagnostics include mandatory complete blood count (CBC) for administration of clozapine, a drug used in the treatment of severe schizophrenia.
Factors Affecting Companion Diagnostic Market Growth
-
Increasing demand for companion diagnostic in cancer drug
Increasing demand for companion diagnostics in cancer drugs is the major factor expected to drive the growth of the companion diagnostics market. increasing incidences of cancer. A growing number of targeted anticancer drugs are developing under development companion diagnostics. Additionally, A number of drugs–diagnostic co-development programs and the use of several targeted cancer drugs are guided by a CDx. For instance, according to the World Health Organization (WHO), in 2022, there were 2.26 million new cases of people diagnosed with breast cancer and 2.21 million issues of people diagnosed with lung cancer worldwide. Furthermore, the increasing prevalence of cancer and the popularity of companion diagnostics are due to the benefits of oncology Companion Diagnostics assay. This is expected to drive the growth of the companion diagnostics market.
The Restraining Factor of Companion Diagnostic:
-
High cost associated with the companion diagnostic tests
High cost associated with the companion diagnostic tests. Companion diagnostics are a higher cost of therapy than other diagnostic tests. companion diagnostics may be available but at a significantly higher cost, making them unaffordable for many patients. Furthermore, the other cost-required option available such as chemotherapy is likely to hamper the growth of the companion diagnostics market.
Impact of the COVID-19 Pandemic on the Companion Diagnostics Market
The COVID-19 pandemic has led to supply chain disruptions leading to supply shortages or lower demand in the Companion Diagnostics market. The lockdown and restrictions related to social distancing implemented in these COVID-19 countries had negatively affected the supply chain of these products. Furthermore, clinical trials in oncology have also been affected by the coronavirus. However, the market is booming after the significant efforts taken by governments, healthcare practitioners, and market stakeholders to recover from losses caused due to pandemic.
We have various report editions of Companion Diagnostic Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.
Companion Diagnostic Market Insights Video
Companion Diagnostic Market News
-
Labcorp and OmniSeq have launched a next-generation sequencing platform to advance precision oncology
In June 2021, Labcorp and OmniSeq, has launched of OmniSeq INSIGHTsm, a comprehensive genomic and immune profiling, tissue-based test that integrates next-generation sequencing (NGS) technology. This is designed to advance precision oncology and improve patient outcomes.
Top Companies Market Share in Companion Diagnostic Industry: (In no particular order of Rank)
- Abbott Laboratories Molecular Inc
- Agilent
- ARUP Laboratories Inc
- BioMerieux
- Danaher Corporation
- Foundation Medicine Inc
- Myriad Genetics Inc
- Roche
- Thermo Fisher Scientific
- QIAGEN N.V.
- Confidential Data
- Access The Paid Version
- Data Hidden
If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.
North America Companion Diagnostic held the largest market share in 2022
In 2022, North America dominated the companion diagnostics market and largest market share in terms of revenue. This is due to the increasing prevalence of cancer and the adoption of advanced CDx assays in the region. For instance, according to the National Cancer Institute, an estimated 1,806,590 new cases of cancer were diagnosed in the U.S. in 2020. In addition, increasing affordable treatment and well-established healthcare infrastructure in the region. Furthermore, the number of clinical trials, research activities, and rising healthcare investment by the government. These all factors affect the growth of the companion diagnostics market in this region.
The current report Scope analyzes Companion Diagnostic Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com
- North America (United States, Canada, Mexico)
- Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
- Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
- South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
- Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)
Companion Diagnostic Market Share (%) by Region (2019-2031)
The above graph is for illustrative purposes only. To learn more about geographical trends request the free sample pages. Contact US!
Companion Diagnostic Market Analysis
Global Companion Diagnostic Market Report 2024 Edition talks about crucial market insights with the help of segments and sub-segments analysis. In this section, we reveal an in-depth analysis of the key factors influencing Companion Diagnostic Industry growth. Companion Diagnostic market has been segmented with the help of its Indication, End User Technology, and others. Companion Diagnostic market analysis helps to understand key industry segments, and their global, regional, and country-level insights. Furthermore, this analysis also provides information pertaining to segments that are going to be most lucrative in the near future and their expected growth rate and future market opportunities. The report also provides detailed insights into factors responsible for the positive or negative growth of each industry segment.
Companion Diagnostic Market, By Indication
The oncology segment held the largest revenue market share in 2022
The cancer segment dominated the companion diagnostics market in 2022. This is attributed to companion diagnostics increasing demand for the oncology drug development process and the rising prevalence of cancer, R&D activities for cancer. In addition, increasing unmet needs for cancer treatment, FDA-approved companion diagnostics, and growing awareness about personalized medicine among patients. Furthermore, widely used companion diagnostics in several forms of cancers such as blood cancer, breast cancer, lung cancer, and colorectal cancer, which is affecting the growth of this segment in the companion diagnostics market.
- Cancer
- Infectious Diseases
- Neurological Diseases
- Others
Companion Diagnostic Market Share (%) by Indication in 2019-2031
The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Companion Diagnostic Industry. Request a Free Sample PDF!
End User Segment Analysis of Companion Diagnostic Market
This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends and opportunities for each application of Companion Diagnostic from 2019 to 2031. This will also help to analyze the demand for Companion Diagnostic across different end-use industries. Our research team will also help acquire additional data such as Value Chain, Patent analysis, Company Evaluation Quadrant (Matrix), and much more confidential analysis and data insights.
Some of the key End User of Companion Diagnostic are:
- Pharmaceutical & Biopharmaceutical Companies
- Reference Laboratories
- Others
Companion Diagnostic Market Share (%) by End User in 2019-2031
2019
2023
2031
The above Graph is for representation purposes only. This chart does not depict actual Market share. Please purchase the Companion Diagnostic market report 2024 Edition by contacting our team.
Companion Diagnostic Technology Segment Analysis
- Polymerase Chain Reaction
- In-situ Hybridization
- Immunohistochemistry
- Next Generation Gene Sequencing
- Others
Author's Detail
Anushka GoreResearch Associate at Cognitive Market Research
Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the Pharmaceutical industry. With a keen analytical mind and a deep passion for healthcare advancements, she has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services.
Anushka is a highly motivated and detail-oriented research analyst with a passion for uncovering valuable insights from data. Her expertise in Market Research and business intelligence has equipped her with the skills necessary to analyze complex information and provide strategic recommendations. She thrives in dynamic environments where her analytical abilities and research expertise can contribute to informed decision-making for businesses
I played a pivotal role in conducting market research and competitive analysis. I have a demonstrated ability to synthesize diverse data sources, identify trends, and translate findings into actionable recommendations. My collaborative approach facilitated effective communication of insights, fostering a data-driven culture within the organization. I am committed to maintaining excellence through continuous learning and staying ahead of industry trends. Regular participation in conferences and professional development opportunities keeps my skills sharp and relevant.
Author's Conclusion
Our study will explain complete manufacturing process along with major raw materials required to manufacture end-product. This report helps to make effective decisions determining product position and will assist you to understand opportunities and threats around the globe.
The Global Companion Diagnostic Market is witnessing significant growth in the near future.
In 2023, the Cancer segment accounted for noticeable share of global Companion Diagnostic Market and is projected to experience significant growth in the near future.
The Pharmaceutical & Biopharmaceutical Companies segment is expected to expand at the significant CAGR retaining position throughout the forecast period.
Some of the key companies Abbott Laboratories Molecular Inc , ARUP Laboratories Inc and others are focusing on its strategy building model to strengthen its product portfolio and expand its business in the global market.
Frequently Asked Questions
Latest News about Companion Diagnostic Market
- http://www.trade.gov
- http://www.gov.uk
- http://www.fda.gov
- http://www.hhs.gov
- http://www.who.int
- http://www.bls.gov
- http://www.gao.gov
- http://www.ncbi.nlm.nih.gov
- http://www.healthcaredive.com
- http://www.export.gov
- http://www.weforum.org
- http://www.health.gov.za
- http://www.usaid.gov
- http://www.eumdr.com
- http://www.cdc.gov
- http://www.ama-assn.org
- http://www.washingtonpost.com
- http://www.ecfr.gov
- http://www.hbr.org
- http://www.worldbank.org
- http://www.commission.europa.eu
- http://www.cbi.eu
- http://www.unicef.org
- http://www.ecipe.org
- http://www.ema.europa.eu
Companion Diagnostic Market Report Table of Content
Disclaimer:
- This is just a redacted sample pages of the actual deliverable report and only for representative purposes
- Charts/Graphs/Numbers/data are only for Representative purposes and do not depict actual statistics.
- The table of Contents differs according to the user License selection. Current Displayed TOC is for the Corporate User License Report Edition. TOC Customization options: Add or Remove section/s Or chapter/s from the report.
- Specific Tables, Graphs, Sections, and Chapters can be ordered at a discounted price.
- If applicable; On Request Volume Data will also be provided (at an Additional Cost).
| Indication | Cancer, Infectious Diseases, Neurological Diseases, Others |
| End User | Pharmaceutical & Biopharmaceutical Companies, Reference Laboratories, Others |
| Technology | Polymerase Chain Reaction, In-situ Hybridization, Immunohistochemistry, Next Generation Gene Sequencing, Others |
| List of Competitors | Abbott Laboratories Molecular Inc, Agilent, ARUP Laboratories Inc, BioMerieux, Danaher Corporation, Foundation Medicine Inc, Myriad Genetics Inc, Roche, Thermo Fisher Scientific, QIAGEN N.V. |
This chapter will help you gain GLOBAL Market Analysis of Companion Diagnostic. Further deep in this chapter, you will be able to review Global Companion Diagnostic Market Split by various segments and Geographical Split.
Chapter 1 Global Market Analysis
-
1.1 Global Companion Diagnostic Market Size, Trend Analysis 2019 - 2031
-
1.2 Global Companion Diagnostic Market Size By Regions 2019 - 2031
Global Market has been segmented on the basis 5 major regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
-
1.2.1 Global Companion Diagnostic Revenue Market Size By Region
-
-
1.3 Global Companion Diagnostic Market Size By Indication 2019 -2031
-
1.3.1 Cancer Market Size
-
1.3.2 Infectious Diseases Market Size
-
1.3.3 Neurological Diseases Market Size
-
1.3.4 Others Market Size
-
-
1.4 Global Companion Diagnostic Market Size By End User 2019 -2031
-
1.4.1 Pharmaceutical & Biopharmaceutical Companies Market Size
-
1.4.2 Reference Laboratories Market Size
-
1.4.3 Others Market Size
-
-
1.5 Global Companion Diagnostic Market Size By Technology 2019 -2031
-
1.5.1 Polymerase Chain Reaction Market Size
-
1.5.2 In-situ Hybridization Market Size
-
1.5.3 Immunohistochemistry Market Size
-
1.5.4 Next Generation Gene Sequencing Market Size
-
1.5.5 Others Market Size
-
-
1.6 Global Level Competitor Analysis (Subject to Data Availability (Private Players))
-
1.7 Executive Summary Global Market (2019 vs 2024 vs 2031)
You can purchase only the Executive Summary of Global Market (2019 vs 2024 vs 2031)
-
1.7.1 Regional Market Revenue Summary 2019 vs 2024 vs 2031
-
1.7.2 Global Market Revenue Split By Indication
-
1.7.3 Global Market Revenue Split By End User
-
1.7.4 Global Market Revenue Split By Technology
-
1.7.5 Global Market Dynamics, Trends, Drivers, Restraints, Opportunities
Global Market Dynamics, Trends, Drivers, Restraints, Opportunities, Only Pointers will be deliverable
-
Chapter 2 North America Market Analysis
-
2.1 North America Companion Diagnostic Market Size 2019 - 2031
-
2.1.1 North America Companion Diagnostic Market Size By Country 2019 - 2031
-
2.1.2 North America Companion Diagnostic Market Size by Indication 2019 -2031
-
2.1.2.1 North America Cancer Market Size
-
2.1.2.2 North America Infectious Diseases Market Size
-
2.1.2.3 North America Neurological Diseases Market Size
-
2.1.2.4 North America Others Market Size
-
-
2.1.3 North America Companion Diagnostic Market Size by End User 2019 -2031
-
2.1.3.1 North America Pharmaceutical & Biopharmaceutical Companies Market Size
-
2.1.3.2 North America Reference Laboratories Market Size
-
2.1.3.3 North America Others Market Size
-
-
2.1.4 North America Companion Diagnostic Market Size by Technology 2019 -2031
-
2.1.4.1 North America Polymerase Chain Reaction Market Size
-
2.1.4.2 North America In-situ Hybridization Market Size
-
2.1.4.3 North America Immunohistochemistry Market Size
-
2.1.4.4 North America Next Generation Gene Sequencing Market Size
-
2.1.4.5 North America Others Market Size
-
-
-
2.2 Add-Ons: Customize the Report Edition
Purchase Add-Ons to Customize the Report Edition and get further granular data level data about the North America market. Add-On Cost: Request before placing the order, Respective Pricing will be informed after sending the inquiry
-
2.2.1 North America Company Market Share 2019 till 2023
-
2.2.2 Qualitative Analysis for North America Market
Qualitative Analysis for the North America Market: North America Companion Diagnostic Market Trends North America Companion Diagnostic Technological Road Map North America Companion Diagnostic Market Drivers North America Companion Diagnostic Market Restraints North America Companion Diagnostic Market Opportunity Market Attractiveness Analysis COVID – 19 Impact Analysis PESTEL Analysis Porter’s Five Forces Analysis Product Life Cycle Industrial Chain Analysis
-
-
2.3 Executive Summary North America Market (2019 vs 2024 vs 2031)
You can purchase only the Executive Summary North America Market (2019 vs 2024 vs 2031)
-
2.3.1 North America Market Summary 2019 vs 2024 vs 2031
-
2.3.2 North America Market Revenue Split By Indication
-
2.3.3 North America Market Revenue Split By End User
-
2.3.4 North America Market Revenue Split By Technology
-
Chapter 3 Europe Market Analysis
-
3.1 Europe Companion Diagnostic Market Size 2019 - 2031
-
3.1.1 Europe Companion Diagnostic Market Size By Country 2019 - 2031
-
3.1.2 Europe Companion Diagnostic Market Size by Indication 2019 -2031
-
3.1.2.1 Europe Cancer Market Size
-
3.1.2.2 Europe Infectious Diseases Market Size
-
3.1.2.3 Europe Neurological Diseases Market Size
-
3.1.2.4 Europe Others Market Size
-
-
3.1.3 Europe Companion Diagnostic Market Size by End User 2019 -2031
-
3.1.3.1 Europe Pharmaceutical & Biopharmaceutical Companies Market Size
-
3.1.3.2 Europe Reference Laboratories Market Size
-
3.1.3.3 Europe Others Market Size
-
-
3.1.4 Europe Companion Diagnostic Market Size by Technology 2019 -2031
-
3.1.4.1 Europe Polymerase Chain Reaction Market Size
-
3.1.4.2 Europe In-situ Hybridization Market Size
-
3.1.4.3 Europe Immunohistochemistry Market Size
-
3.1.4.4 Europe Next Generation Gene Sequencing Market Size
-
3.1.4.5 Europe Others Market Size
-
-
-
3.2 Add-Ons: Customize the Report Edition
-
3.2.1 Europe Company Market Share 2019 till 2023
-
3.2.2 Qualitative Analysis for Europe Market
-
-
3.3 Executive Summary Europe Market (2019 vs 2024 vs 2031)
You can purchase only the Executive Summary Europe Market (2019 vs 2024 vs 2031)
-
3.3.1 Europe Revenue Market Summary 2019 vs 2024 vs 2031
-
3.3.2 Europe Market Revenue Split By Indication
-
3.3.3 Europe Market Revenue Split By End User
-
3.3.4 Europe Market Revenue Split By Technology
-
Chapter 4 Asia-Pacific Market Analysis
-
4.1 Asia Pacific Companion Diagnostic Market Size 2019 - 2031
-
4.1.1 Asia Pacific Companion Diagnostic Market Size By Country 2019 - 2031
-
4.1.2 Asia Pacific Companion Diagnostic Market Size by Indication 2019 -2031
-
4.1.2.1 Asia Pacific Cancer Market Size
-
4.1.2.2 Asia Pacific Infectious Diseases Market Size
-
4.1.2.3 Asia Pacific Neurological Diseases Market Size
-
4.1.2.4 Asia Pacific Others Market Size
-
-
4.1.3 Asia Pacific Companion Diagnostic Market Size by End User 2019 -2031
-
4.1.3.1 Asia Pacific Pharmaceutical & Biopharmaceutical Companies Market Size
-
4.1.3.2 Asia Pacific Reference Laboratories Market Size
-
4.1.3.3 Asia Pacific Others Market Size
-
-
4.1.4 Asia Pacific Companion Diagnostic Market Size by Technology 2019 -2031
-
4.1.4.1 Asia Pacific Polymerase Chain Reaction Market Size
-
4.1.4.2 Asia Pacific In-situ Hybridization Market Size
-
4.1.4.3 Asia Pacific Immunohistochemistry Market Size
-
4.1.4.4 Asia Pacific Next Generation Gene Sequencing Market Size
-
4.1.4.5 Asia Pacific Others Market Size
-
-
-
4.2 Add-Ons: Customize the Report Edition
-
4.2.1 Asia Pacific Company Market Share 2019 till 2023
-
4.2.2 Qualitative Analysis for Asia Pacific Market
-
-
4.3 Executive Summary Asia Pacific Market (2019 vs 2024 vs 2031)
You can purchase only the Executive Summary Asia Pacific Market (2019 vs 2024 vs 2031)
-
4.3.1 Asia Pacific Market Summary 2019 vs 2024 vs 2031
-
4.3.2 Asia Pacific Market Revenue Split By Indication
-
4.3.3 Asia Pacific Market Revenue Split By End User
-
4.3.4 Asia Pacific Market Revenue Split By Technology
-
Chapter 5 South America Market Analysis
-
5.1 South America Companion Diagnostic Market Size 2019 - 2031
-
5.1.1 South America Companion Diagnostic Revenue Market Size By Country 2019 - 2031
-
5.1.2 South America Companion Diagnostic Market Size by Indication 2019 -2031
-
5.1.2.1 South America Cancer Market Size
-
5.1.2.2 South America Infectious Diseases Market Size
-
5.1.2.3 South America Neurological Diseases Market Size
-
5.1.2.4 South America Others Market Size
-
-
5.1.3 South America Companion Diagnostic Market Size by End User 2019 -2031
-
5.1.3.1 South America Pharmaceutical & Biopharmaceutical Companies Market Size
-
5.1.3.2 South America Reference Laboratories Market Size
-
5.1.3.3 South America Others Market Size
-
-
5.1.4 South America Companion Diagnostic Market Size by Technology 2019 -2031
-
5.1.4.1 South America Polymerase Chain Reaction Market Size
-
5.1.4.2 South America In-situ Hybridization Market Size
-
5.1.4.3 South America Immunohistochemistry Market Size
-
5.1.4.4 South America Next Generation Gene Sequencing Market Size
-
5.1.4.5 South America Others Market Size
-
-
-
5.2 Add-Ons: Customize the Report Edition
-
5.2.1 South America Company Market Share 2019 till 2023
-
5.2.2 Qualitative Analysis for South America Market
-
-
5.3 Executive Summary South America Market (2019 vs 2024 vs 2031)
You can purchase only the Executive Summary South America Market (2019 vs 2024 vs 2031)
-
5.3.1 South America Market Summary 2019 vs 2024 vs 2031
-
5.3.2 South America Market Revenue Split By Indication
-
5.3.3 South America Market Revenue Split By End User
-
5.3.4 South America Market Revenue Split By Technology
-
Chapter 6 Middle East and Africa Market Analysis
-
6.1 Middle East and Africa Companion Diagnostic Market Size 2019 - 2031
-
6.1.1 Middle East and Africa Companion Diagnostic Revenue Market Size By Country 2019 - 2031
-
6.1.2 Middle East and Africa Companion Diagnostic Market Size by Indication 2019 -2031
-
6.1.2.1 Middle East and Africa Cancer Market Size
-
6.1.2.2 Middle East and Africa Infectious Diseases Market Size
-
6.1.2.3 Middle East and Africa Neurological Diseases Market Size
-
6.1.2.4 Middle East and Africa Others Market Size
-
-
6.1.3 Middle East and Africa Companion Diagnostic Market Size by End User 2019 -2031
-
6.1.3.1 Middle East and Africa Pharmaceutical & Biopharmaceutical Companies Market Size
-
6.1.3.2 Middle East and Africa Reference Laboratories Market Size
-
6.1.3.3 Middle East and Africa Others Market Size
-
-
6.1.4 Middle East and Africa Companion Diagnostic Market Size by Technology 2019 -2031
-
6.1.4.1 Middle East and Africa Polymerase Chain Reaction Market Size
-
6.1.4.2 Middle East and Africa In-situ Hybridization Market Size
-
6.1.4.3 Middle East and Africa Immunohistochemistry Market Size
-
6.1.4.4 Middle East and Africa Next Generation Gene Sequencing Market Size
-
6.1.4.5 Middle East and Africa Others Market Size
-
-
-
6.2 Add-Ons: Customize the Report Edition
-
6.2.1 Middle East and Africa Company Market Share 2019 till 2023
-
6.2.2 Qualitative Analysis for Middle East and Africa Market
-
-
6.3 Executive Summary Middle East and Africa Market (2019 vs 2024 vs 2031)
You can purchase only the Executive Summary Middle East and Africa Market (2019 vs 2024 vs 2031)
-
6.3.1 Middle East and Africa Market Summary 2019 vs 2024 vs 2031
-
6.3.2 Middle East and Africa Market Revenue Split By Indication
-
6.3.3 Middle East and Africa Market Revenue Split By End User
-
6.3.4 Middle East and Africa Market Revenue Split By Technology
-
Only Available with Corporate User License
Chapter 7 Top 10 Countries Analysis
-
7.1 Country 1 Market Analysis
-
7.1.1 Country 1Companion Diagnostic Market Size by Indication 2019 -2031
-
7.1.2 Country 1Companion Diagnostic Market Size by End User 2019 -2031
-
7.1.3 Country 1Companion Diagnostic Market Size by Technology 2019 -2031
-
-
7.2 Country 2 Market Analysis
-
7.2.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.3 Country 3 Market Analysis
-
7.3.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.4 Country 4 Market Analysis
-
7.4.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.5 Country 5 Market Analysis
-
7.5.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.6 Country 6 Market Analysis
-
7.6.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.7 Country 7 Market Analysis
-
7.7.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.8 Country 8 Market Analysis
-
7.8.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.9 Country 9 Market Analysis
-
7.9.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.10 Country 10 Market Analysis
-
7.10.1 Segmentation Analysis will be provided as shown for Country 1
-
Competitor's Market Share and Revenue (Subject to Data Availability for Private Players)
Chapter 8 Competitor Analysis (Subject to Data Availability (Private Players))
-
8.1 Top Competitors Analysis
-
8.1.1 Top Players Ranking 2022
-
8.1.2 Global Companion Diagnostic Market Revenue and Share by Manufacturers (2019-2023)
(Subject to Data Availability (Private Players))
-
8.1.3 Industry Mergers and Acquisition Analysis
-
8.1.4 New Product Launch Analysis
-
-
8.2 Company Profile (Data Subject to Availability)
-
8.2.1 Abbott Laboratories Molecular Inc
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.1.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.1.2 Business Overview
-
8.2.1.3 Financials (Subject to data availability)
-
8.2.1.4 Product Types Specification
-
8.2.1.5 Business Strategy
-
8.2.1.6 S.W.O.TAnalysis
-
-
8.2.2 Agilent
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.2.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.2.2 Business Overview
-
8.2.2.3 Financials (Subject to data availability)
-
8.2.2.4 Product Types Specification
-
8.2.2.5 Business Strategy
-
8.2.2.6 S.W.O.TAnalysis
-
-
8.2.3 ARUP Laboratories Inc
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.3.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.3.2 Business Overview
-
8.2.3.3 Financials (Subject to data availability)
-
8.2.3.4 Product Types Specification
-
8.2.3.5 Business Strategy
-
8.2.3.6 S.W.O.TAnalysis
-
-
8.2.4 BioMerieux
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.4.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.4.2 Business Overview
-
8.2.4.3 Financials (Subject to data availability)
-
8.2.4.4 Product Types Specification
-
8.2.4.5 Business Strategy
-
8.2.4.6 S.W.O.TAnalysis
-
-
8.2.5 Danaher Corporation
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.5.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.5.2 Business Overview
-
8.2.5.3 Financials (Subject to data availability)
-
8.2.5.4 Product Types Specification
-
8.2.5.5 Business Strategy
-
8.2.5.6 S.W.O.TAnalysis
-
-
8.2.6 Foundation Medicine Inc
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.6.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.6.2 Business Overview
-
8.2.6.3 Financials (Subject to data availability)
-
8.2.6.4 Product Types Specification
-
8.2.6.5 Business Strategy
-
8.2.6.6 S.W.O.TAnalysis
-
-
8.2.7 Myriad Genetics Inc
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.7.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.7.2 Business Overview
-
8.2.7.3 Financials (Subject to data availability)
-
8.2.7.4 Product Types Specification
-
8.2.7.5 Business Strategy
-
8.2.7.6 S.W.O.TAnalysis
-
-
8.2.8 Roche
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.8.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.8.2 Business Overview
-
8.2.8.3 Financials (Subject to data availability)
-
8.2.8.4 Product Types Specification
-
8.2.8.5 Business Strategy
-
8.2.8.6 S.W.O.TAnalysis
-
-
8.2.9 Thermo Fisher Scientific
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.9.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.9.2 Business Overview
-
8.2.9.3 Financials (Subject to data availability)
-
8.2.9.4 Product Types Specification
-
8.2.9.5 Business Strategy
-
8.2.9.6 S.W.O.TAnalysis
-
-
8.2.10 QIAGEN N.V.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.10.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.10.2 Business Overview
-
8.2.10.3 Financials (Subject to data availability)
-
8.2.10.4 Product Types Specification
-
8.2.10.5 Business Strategy
-
8.2.10.6 S.W.O.TAnalysis
-
-
Chapter 9 Qualitative Analysis (Subject to Data Availability)
-
9.1 Market Drivers
-
9.2 Market Trends
-
9.3 Market Restraints
-
9.4 Market Opportunity
-
9.5 Product Life Cycle (Subject to Data Availability)
-
9.6 Industrial Chain Analysis (Subject to Data Availability)
-
9.6.1 Industry Chain Analysis
-
9.6.2 Manufacturing Cost Analysis
-
9.6.3 Consumer Preference Analysis
-
9.6.4 Supply Side Analysis
-
9.6.4.1 Raw Material Analysis
-
9.6.4.2 Raw Material Procurement Analysis
-
9.6.4.3 Raw Material Price Trend Analysis
-
-
-
9.7 Market Attractiveness Analysis
-
9.8 PESTEL Analysis
-
9.9 Porter’s Five Forces Analysis
-
9.10 Patent Analysis (Subject to Data Availability)
-
9.11 ESG Analysis
-
9.12 Technological Road Map
Segmentation Indication Analysis 2019 -2031, will provide market size split by Indication. This Information is provided at Global Level, Regional Level and Top Countries Level The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 10 Market Split by Indication Analysis 2019 -2031
-
10.1 Cancer
-
10.1.1 Global Companion Diagnostic Revenue Market Size and Share by Cancer 2019 -2031
-
-
10.2 Infectious Diseases
-
10.2.1 Global Companion Diagnostic Revenue Market Size and Share by Infectious Diseases 2019 -2031
-
-
10.3 Neurological Diseases
-
10.3.1 Global Companion Diagnostic Revenue Market Size and Share by Neurological Diseases 2019 -2031
-
-
10.4 Others
-
10.4.1 Global Companion Diagnostic Revenue Market Size and Share by Others 2019 -2031
-
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 11 Market Split by End User Analysis 2019 -2031
-
11.1 Pharmaceutical & Biopharmaceutical Companies
-
11.1.1 Global Companion Diagnostic Revenue Market Size and Share by Pharmaceutical & Biopharmaceutical Companies 2019 - 2031
-
-
11.2 Reference Laboratories
-
11.2.1 Global Companion Diagnostic Revenue Market Size and Share by Reference Laboratories 2019 - 2031
-
-
11.3 Others
-
11.3.1 Global Companion Diagnostic Revenue Market Size and Share by Others 2019 - 2031
-
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 12 Market Split by Technology Analysis 2019 -2031
-
12.1 Polymerase Chain Reaction
-
12.1.1 Global Companion Diagnostic Revenue Market Size and Share by Polymerase Chain Reaction 2019 -2031
-
-
12.2 In-situ Hybridization
-
12.2.1 Global Companion Diagnostic Revenue Market Size and Share by In-situ Hybridization 2019 -2031
-
-
12.3 Immunohistochemistry
-
12.3.1 Global Companion Diagnostic Revenue Market Size and Share by Immunohistochemistry 2019 -2031
-
-
12.4 Next Generation Gene Sequencing
-
12.4.1 Global Companion Diagnostic Revenue Market Size and Share by Next Generation Gene Sequencing 2019 -2031
-
-
12.5 Others
-
12.5.1 Global Companion Diagnostic Revenue Market Size and Share by Others 2019 -2031
-
This chapter helps you understand the Key Takeaways and Analyst Point of View of the global Companion Diagnostic market
Chapter 13 Research Findings
-
13.1 Key Takeaways
-
13.2 Analyst Point of View
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.
-
13.3 Assumptions and Acronyms
Sample Format of Deliverables
The Tables, Graphs/Charts are only for representative purposes and do not depict actual statistics. Purchase full Report access to actual data.
Qualitative Analysis
Research Methodology Implemented by Anushka Gore and Team
- 1.1 Companion Diagnostic Market Report 2024 Research Methodology
- 1.2 Systematic Research Approach
- 1.2.1 Primary Research for Companion Diagnostic Market
- 1.2.1.1 Key Data from Primary
- 1.2.1.2 Primary Interviews with Experts
- 1.2.1.3 Key Industry Insights
- 1.2.1.4 Questionnaire for Companion Diagnostic Market
- 1.2.1.5 Breakdown of Primaries
- 1.2.2 Secondary Research for Companion Diagnostic Market
- 1.2.2.1 Key Data from Secondary
- 1.2.2.2 Paid Sources
- 1.2.2.3 Public Sources
- 1.3 Market Size Estimation for Companion Diagnostic Market
- 1.3.1 Top-Down Approach
- 1.3.1.1 Analyzing Market Size by Top-Down Approach (Supply Side)
- 1.3.2 Bottom-UP Approach
- 1.3.2.1 Analyzing Market Size by Bottom-Up Approach (Demand Side)
- 1.3.1 Top-Down Approach
- 1.4 Market Breakdown and Data Triangulation
- 1.5 Research Assumptions for Companion Diagnostic Market
Key Questions Answered By Companion Diagnostic Market Report 2024
| Why Cancer have a significant impact on Companion Diagnostic market? |
| What are the key factors affecting the Cancer and Infectious Diseases of Companion Diagnostic Market? |
| What is the CAGR/Growth Rate of Pharmaceutical & Biopharmaceutical Companies during the forecast period? |
| By type, which segment accounted for largest share of the global Companion Diagnostic Market? |
| Which region is expected to dominate the global Companion Diagnostic Market within the forecast period? |
| Segmentation Level Customization |
|
| Global level Data Customization |
|
| Region level Data Customization |
|
| Country level Data Customization |
|
| Company Level |
|
| Additional Data Analysis |
|
| Additional Qualitative Data |
|
| Additional Quantitative Data |
|
| Service Level Customization |
|
Report Format Alteration |
|
